The quality of reporting methods and results of cost-effectiveness analyses in Spain: a methodological systematic review

Systematic Reviews
Ferrán Catalá-LópezBrian Hutton

Abstract

Cost-effectiveness analysis has been recognized as an important tool to determine the efficiency of healthcare interventions and services. There is a need for evaluating the reporting of methods and results of cost-effectiveness analyses and establishing their validity. We describe and examine reporting characteristics of methods and results of cost-effectiveness analyses conducted in Spain during more than two decades. A methodological systematic review was conducted with the information obtained through an updated literature review in PubMed and complementary databases (e.g. Scopus, ISI Web of Science, National Health Service Economic Evaluation Database (NHS EED) and Health Technology Assessment (HTA) databases from Centre for Reviews and Dissemination (CRD), Índice Médico Español (IME) Índice Bibliográfico Español en Ciencias de la Salud (IBECS)). We identified cost-effectiveness analyses conducted in Spain that used quality-adjusted life years (QALYs) as outcome measures (period 1989-December 2014). Two reviewers independently extracted the data from each paper. The data were analysed descriptively. In total, 223 studies were included. Very few studies (10; 4.5 %) reported working from a protocol. Most studies (200; 89.7 %...Continue Reading

References

Mar 1, 1995·Health Economics·J Mason, M Drummond
Oct 23, 1996·JAMA : the Journal of the American Medical Association·J E SiegelM R Gold
May 26, 1998·Medical Care·A ElixhauserB R Luce
May 3, 2000·JAMA : the Journal of the American Medical Association·D Rennie, H S Luft
Jun 17, 2000·Annals of Internal Medicine·P J NeumannC M Bell
Jun 29, 2000·JAMA : the Journal of the American Medical Association·D RennieV Yank
Jun 1, 2002·JAMA : the Journal of the American Medical Association·Tom JeffersonLuke Vale
Jan 22, 2003·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Milton C WeinsteinUNKNOWN ISPOR Task Force on Good Research Practices--Modeling Studies
Mar 30, 2005·Lancet·An-Wen Chan, Douglas G Altman
Apr 22, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Peter J NeumannAllison B Rosen
Aug 3, 2005·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Allison B RosenPeter J Neumann
Sep 24, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Scott RamseyShelby Reed
Feb 24, 2006·Health Economics·Mark J SculpherChris McCabe
Feb 24, 2006·BMJ : British Medical Journal·Chaim M BellPeter J Neumann
Dec 30, 2006·Revista española de cardiología·José M ValderasJordi Alonso
Mar 29, 2007·PLoS Medicine·David MoherDouglas G Altman
Jun 16, 2009·Lancet·Iain Chalmers, Paul Glasziou
Jul 23, 2009·Annals of Internal Medicine·David MoherUNKNOWN PRISMA Group
Oct 7, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Morgan E LimJean-Eric Tarride
Feb 17, 2010·BMJ : British Medical Journal·Jamie J KirkhamPaula R Williamson
Mar 25, 2010·BMJ : British Medical Journal·Sally HopewellDouglas G Altman
Mar 25, 2010·BMJ : British Medical Journal·David MoherDouglas G Altman
Mar 26, 2010·Annals of Internal Medicine·Kenneth F SchulzUNKNOWN CONSORT Group
Apr 21, 2010·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Julio López-BastidaJaume Puig-Junoy
Dec 15, 2010·Revista española de salud pública·Ferrán Catalá-López, Anna García-Altés
Jun 11, 2011·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·José Manuel Rodríguez BarriosMax Brosa Riestra
Jun 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·José Manuel RodriguezPaloma Gonzalez
Jan 9, 2013·Annals of Internal Medicine·An-Wen ChanDavid Moher
Mar 28, 2013·BMC Medicine·Don HusereauUNKNOWN CHEERS Task Force
Aug 27, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Maria-Florencia HutterFernando Antonanzas
Jan 15, 2014·Lancet·John P A IoannidisRobert Tibshirani
Nov 25, 2014·BMJ : British Medical Journal·Pooja SainiJamie J Kirkham

❮ Previous
Next ❯

Citations

Jul 18, 2016·Atencion primaria·Ferrán Catalá-López, Manuel Ridao
Jul 23, 2016·Revista Española De Cardiología·Manuel Ridao, Ferrán Catalá-López
Feb 21, 2019·Community Dentistry and Oral Epidemiology·Raul PalacioChristopher Robert Vernazza
Apr 16, 2019·Critical Care Medicine·M Elizabeth WilcoxChaim M Bell
Nov 2, 2019·Health and Quality of Life Outcomes·Lidia García-PérezAmaia Bilbao
Apr 18, 2020·The British Journal of Radiology·Silanath Terpenning, Arthur Stillman
Oct 3, 2017·American Journal of Clinical Pathology·Justin E CaronRobert L Schmidt
Aug 5, 2017·The Laryngoscope·Jorge Pérez-MartínFrancisco J Díez
Apr 14, 2021·Value in Health Regional Issues·Majed A AlgarniAbdulaziz I Alzarea

❮ Previous
Next ❯

Software Mentioned

PRISMA
Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.